Two years ago, we launched the o2h Kickstarter program with the aim of empowering biotech startups at crucial moments in their drug discovery journey. We’re pleased to have supported more than 𝟐𝟎 innovative biotech startups all over the world, helping them progress their novel drug development and beyond.
One of our standout success stories is that of Origami Therapeutics, Inc., whose groundbreaking work in the initial phase of structure-activity relationship (SAR) studies has gained momentum. Read more…